🔗 Share this article

Chancellor Rachel Reeves has announced she is planning "targeted action to tackle cost of living challenges" in the forthcoming Budget.

In comments to media outlets, she stated that reducing price rises is a collective responsibility of both the administration and the central bank.

The United Kingdom's price growth is expected to be the highest among the Group of Seven developed nations this year and next.

Possible Energy Bill Measures

It is understood the administration could intervene to reduce utility costs, for instance by slashing the present 5% rate of value-added tax charged on energy.

A further possibility is to lower some of the policy costs currently added to bills.

Fiscal Constraints and Analyst Expectations

The government will obtain the latest report from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much room there is for these actions.

The consensus from most analysts is that Reeves will have to announce tax increases or spending cuts in order to meet her declared fiscal targets.

Earlier on Thursday, analysis showed there was a twenty-two billion pound deficit for the Treasury chief to address, which is at the lower end of projections.

"There's a joint task between the central bank and the administration to continue tackling some of the causes of inflation," Reeves informed reporters in Washington, at the conferences of the International Monetary Fund and global financial institution.

Revenue Pledges and Global Concerns

While a great deal of the focus has been on expected tax increases, the chancellor said the latest figures from the fiscal watchdog had not changed her commitment to manifesto promises not to increase rates on income tax, sales tax or National Insurance.

She attributed an "uncertain world" with increasing geopolitical and commercial concerns for the Budget revenue measures, probably to be targeted on those "with the broadest shoulders."

Global Trade Tensions

Referring to concerns about the UK's commercial links with China she said: "The UK's national security invariably are paramount."

Last week's statement by Chinese authorities to increase trade restrictions on critical minerals and other resources that are crucial for advanced tech manufacturing led American leader the US President to propose an additional 100% tariff on goods from China, increasing the possibility of an all-out trade war between the two economic giants.

The American finance chief called China's move "commercial pressure" and "a international production power grab."

Inquired about accepting the American proposal to participate in its dispute with the Asian nation, the Chancellor said she was "deeply worried" by Chinese measures and encouraged the Beijing authorities "to avoid restrictions and restrict access."

She said the action was "damaging for the world economy and creates further headwinds."

"It is my opinion there are areas where we need to challenge Chinese policies, but there are also valuable opportunities to sell into Chinese markets, including financial services and other areas of the economy. We've got to get that equilibrium right."

The chancellor also affirmed she was working with international partners "on our own critical minerals approach, so that we are reduced dependence."

Health Service Medicine Costs and Investment

The Chancellor also acknowledged that the cost the NHS spends on medicines could increase as a consequence of current negotiations with the US government and its drugs companies, in return for reduced taxes and investment.

Some of the world's largest drug companies have said in recent statements that they are either pausing or canceling operations in the United Kingdom, with some blaming the insufficient payments they are obtaining.

Last month, the government science advisor said the price the health service pays for medicines would must increase to stop businesses and pharmaceutical investment leaving the UK.

Reeves stated to media: "We have seen because of the pricing regime, that medical research, new drugs have not been offered in the United Kingdom in the extent that they are in other European countries."

"We want to guarantee that individuals receiving treatment from the NHS are able to access the best life-saving treatments in the world. And so we are examining these issues, and... aiming to obtain increased funding into Britain."